CONMED Corp — Director's Dealing 2020

Mar 3, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CONMED CORP (CNMD)
CIK: 0000816956
Period of Report: 2020-02-28

Reporting Person: KENNEDY JOHN JED (VP GM CET)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-02-28	Common Stock	M	325	—	Acquired	4822	Direct
2020-02-28	Common Stock	F	96	$94.64	Disposed	4726	Direct
2020-02-28	Common Stock	M	1250	—	Acquired	5976	Direct
2020-02-28	Common Stock	F	367	$94.64	Disposed	5609	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-02-28	Rsus (restricted Stock Units)	$0	M	325	Disposed	2026-03-01	Common Stock (325)	Direct
2020-02-28	Rsus (restricted Stock Units)	$0	M	1250	Disposed	2029-03-01	Common Stock (1250)	Direct
2020-03-02	Options To Purchase Common Stock	$97.69	A	9500	Acquired	2030-03-02	Common Stock (9500)	Direct
2020-03-02	Rsus (restricted Stock Units)	$0	A	5000	Acquired	2030-03-02	Common Stock (5000)	Direct

Footnotes

F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period.

F2: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period.

F3: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period